Warfarin (Coumadin) plus ciprofloxacin (Cipro), clarithromycin (Biaxin), erythromycin, metronidazole (Flagyl) or trimethoprim-sulfamethoxazole (Bactrim, Septra) | Increased effect of warfarin | Generally within 1 week | Select alternative antibiotic. |
Warfarin plus acetaminophen | Increased bleeding, increased INR | Any time | Use lowest possible acetaminophen dosage and monitor INR. |
Warfarin plus acetylsalicylic acid (aspirin) | Increased bleeding, increased INR | Any time | Limit aspirin dosage to 100 mg per dayand monitor INR. |
Warfarin plus NSAID | Increased bleeding, increased INR | Any time | Avoid concomitant use if possible; if coadministration is necessary, use a cyclooxygenase-2 inhibitor and monitor INR. |
Fluoroquinolone plus divalent/trivalent cations or sucralfate (Carafate) | Decreased absorption of fluoroquinolone | Any time | Space administration by 2 to 4 hours. |
Carbamazepine (Tegretol) plus cimetidine (Tagamet), erythromycin, clarithromycin or fluconazole (Diflucan) | Increased carbamazepine levels | Generally within 1 week | Monitor carbamazepine levels. |
Phenytoin (Dilantin) plus cimetidine, erythromycin, clarithromycin or fluconazole | Increased phenytoin levels | Generally within 1 week | Monitor phenytoin levels. |
Phenobarbital plus cimetidine, erythromycin, clarithromycin or fluconazole | Increased phenobarbital levels | Generally within 1 week | Clinical significance has not been established. Monitor phenobarbital levels. |
Phenytoin plus rifampin (Rifadin) | Decreased phenytoin levels | Generally within 1 week | Clinical significance has not been established. Monitor phenytoin levels. |
Phenobarbital plus rifampin | Decreased phenobarbital levels | Generally within 1 week | Monitor phenobarbital levels. |
Carbamazepine plus rifampin | Decreased carbamazepine levels | Generally within 1 week | Clinical significance has not been established. Monitor carbamazepine levels. |
Lithium plus NSAID or diuretic | Increased lithium levels | Any time | Decrease lithium dosage by 50% and monitor lithium levels. |
Oral contraceptive pills plus rifampin | Decreased effectiveness of oral contraception | Any time | Avoid if possible. If combination therapy is necessary, have the patient take an oral contraceptive pill with a higher estrogen content (>35 μg of ethinyl estradiol) or recommend alternative method of contraception. |
Oral contraceptive pills plus antibiotics | Decreased effectiveness of oral contraception | Any time | Avoid if possible. If combination therapy is necessary, recommend use of alternative contraceptive method during cycle. |
Oral contraceptive pills plus troglitazone (Rezulin) | Decreased effectiveness of oral contraception | Any time | Have the patient take an oral contraceptive pill with a higher estrogen content or recommend alternative method of contraception. |
Cisapride (Propulsid) plus erythromycin, clarithromycin, fluconazole, itraconazole (Sporanox), ketoconazole (Nizoral), nefazodone (Serzone), indinavir (Crixivan) or ritonavir (Norvir) | Prolongation of QT interval along with arrhythmias secondary to inhibited cisapride metabolism | Generally within 1 week | Avoid. Consider whether metoclopromide (Reglan) therapy is appropriate for the patient. |
Cisapride plus class IA or class III antiarrhythmic agents, tricyclic antidepressants or phenothiazine | Prolongation of QT interval along with arrhythmias | Any time | Avoid. Consider whether metoclopromide therapy is appropriate for the patient. |
Sildenafil (Viagra) plus nitrates | Dramatic hypotension | Soon after taking sildenafil | Absolute contraindication. |
Sildenafil plus cimetidine, erythromycin, itraconazole or ketoconazole | Increased sildenafil levels | Any time | Initiate sildenafil at a 25-mg dose. |
HMG-CoA reductase inhibitor plus niacin, gemfibrozil (Lopid), erythromycin or itraconazole | Possible rhabdomyolysis | Any time | Avoid if possible. If combination therapy is necessary, monitor the patient for toxicity. |
Lovastatin (Mevacor) plus warfarin | Increased effect of warfarin | Any time | Monitor INR. |
SSRI plus tricyclic antidepressant | Increased tricyclic antidepressant level | Any time | Monitor for anticholinergic excess and consider lower dosage of tricyclic antidepressant. |
SSRI plus selegiline (Eldepryl) or nonselective monoamine oxidase inhibitor | Hypertensive crisis | Soon after initiation | Avoid. |
SSRI plus tramadol (Ultram) | Increased potential for seizures; serotonin syndrome | Any time | Monitor the patient for signs and symptoms of serotonin syndrome. |
SSRI plus St. John's wort | Serotonin syndrome | Any time | Avoid. |
SSRI plus naratriptan (Amerge), rizatriptan (Mazalt), sumatriptan (Imitrex) or zolmitriptan (Zomig) | Serotonin syndrome | Possibly after initial dose | Avoid if possible. If combination therapy is necessary, monitor the patient for signs and symptoms of serotonin syndrome. |